Nicox appoints ad hoc representative
Analysis based on 6 articles · First reported Jun 03, 2026 · Last updated Jun 03, 2026
The appointment of an ad hoc representative ensures the NicOx shareholder meeting will proceed with a 100% quorum, providing clarity on corporate governance. This reduces uncertainty for investors regarding the company's operational decisions and future direction.
NicOx, an international ophthalmology company, announced its Ordinary and Extraordinary General Meeting will be held on June 24, 2026. Due to significant difficulties in reaching the required quorum, the France — Antibes Commercial Court appointed SCP EZAVIN-THOMAS, represented by Maître Thibault Ezavin, as an ad hoc representative. This representative will ensure 100% quorum by representing defaulting shareholders, with specific voting rules for ordinary and extraordinary resolutions to maintain neutrality. Shareholders can participate by proxy, internet, or in person.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard